A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E–Deficient Mice
Top Cited Papers
- 1 January 2012
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 59 (3), 265-276
- https://doi.org/10.1016/j.jacc.2011.07.053
Abstract
No abstract availableFunding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 16 references indexed in Scilit:
- Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4Diabetes, 2010
- Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responsesBMC Immunology, 2009
- Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell functionTrends in Immunology, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Primary Prevention of Cardiovascular Diseases in People With Diabetes MellitusCirculation, 2007
- The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetesThe Lancet, 2006
- Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery diseaseAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Extracellular signal-regulated kinase and p38 mitogen-activated protein kinase mediate macrophage proliferation induced by oxidized low-density lipoproteinAtherosclerosis, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- Inflammation in atherosclerosisNature, 2002